ConductScience.org, home

Paper38065418

Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo.

Yuan Y and 3 others. Neurotoxicology, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo. Papers, record 38065418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38065418

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo.
PubMed
Journal
Neurotoxicology
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.28, provisional
iCite
Revised in PubMed
2026-05-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yuan YYukun
2Bailey JMJordan M
3Rivera-Lopez GMGretchen M
4Atchison WDWilliam D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amyotrophic Lateral SclerosisMajor topic
Methylmercury CompoundsMajor topic
Mice
Humans
Animals
Superoxide Dismutase-1
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Superoxide Dismutase
Mice, Transgenic
Motor Neurons
Brain Stem
Mutation
Disease Models, Animal
Spinal Cord

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 ES024064NIEHS NIH HHSUnited StatesR01ES024064PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References182

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129982983Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.Mol Neurobiol2019https://conductscience.org/library/papers/29982983PubMed
216909020Excitotoxicity and amyotrophic lateral sclerosis.Neurodegener Dis2005https://conductscience.org/library/papers/16909020PubMed
315264227Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.J Neurosci Res2004https://conductscience.org/library/papers/15264227PubMed
421839771Ca2+ entry pathways in mouse spinal motor neurons in culture following in vitro exposure to methylmercury.Neurotoxicology2011https://conductscience.org/library/papers/21839771PubMed
516806844The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.Biochim Biophys Acta2006https://conductscience.org/library/papers/16806844PubMed
632991939AMPA receptor contribution to methylmercury-mediated alteration of intracellular Ca2+ concentration in human induced pluripotent stem cell motor neurons.Neurotoxicology2020https://conductscience.org/library/papers/32991939PubMed
711119696The AMPAR subunit GluR2: still front and center-stage.Brain Res2000https://conductscience.org/library/papers/11119696PubMed
831335339Update on amyotrophic lateral sclerosis genetics.Curr Opin Neurol2019https://conductscience.org/library/papers/31335339PubMed
922072396Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.Mol Neurobiol2012https://conductscience.org/library/papers/22072396PubMed
109223540Action of methylmercury on GABA(A) receptor-mediated inhibitory synaptic transmission is primarily responsible for its early stimulatory effects on hippocampal CA1 excitatory synaptic transmission.J Pharmacol Exp Ther1997https://conductscience.org/library/papers/9223540PubMed
1132159428Acute neurotoxicant exposure induces hyperexcitability in mouse lumbar spinal motor neurons.J Neurophysiol2020https://conductscience.org/library/papers/32159428PubMed
1228528135Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis.Biochim Biophys Acta Mol Basis Dis2017https://conductscience.org/library/papers/28528135PubMed
1324979055Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan.PLoS One2014https://conductscience.org/library/papers/24979055PubMed
1414504315Occurrence of amyotrophic lateral sclerosis among Gulf War veterans.Neurology2003https://conductscience.org/library/papers/14504315PubMed
1522022961Glutamate receptor RNA editing in health and disease.Biochemistry (Mosc)2011https://conductscience.org/library/papers/22022961PubMed
1627350567The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.Sci Rep2016https://conductscience.org/library/papers/27350567PubMed
173655851Three cases of amyotrophic lateral sclerosis in a common occupational environment.J Neurol1987https://conductscience.org/library/papers/3655851PubMed
1832615355CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset.Environ Res2020https://conductscience.org/library/papers/32615355PubMed
194051456Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management.Ann Neurol1985https://conductscience.org/library/papers/4051456PubMed
2016239166Comparative sensitivity of rat cerebellar neurons to dysregulation of divalent cation homeostasis and cytotoxicity caused by methylmercury.Toxicol Appl Pharmacol2005https://conductscience.org/library/papers/16239166PubMed

See all 182 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42864501
Combined rituximab and magnesium acetyl taurate therapy attenuates neurodegeneration via ERK/c-JNK/P38MAPK signaling modulation in methylmercury-induced amyotrophic lateral sclerosis-like neurotoxicity.
Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42864501PubMed
42045773Caffeic Acid Phenethyl Ester Enhanced the Klotho/SIRT1/Nrf2/HO-1 Axis to Protect Against Methylmercury-Induced ALS-Like Neurodegeneration.Mol Neurobiol2026https://conductscience.org/library/papers/42045773PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SOD16647PubTator's text mininghttps://conductscience.org/library/genes/6647

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38065418

GET https://conductscience.org/api/papers/v1/38065418/references?page=2